FCM
SPPI

Farallon Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Farallon Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-250,000
Closed -$4.2M – 105
2018
Q3 		$4.2M Buy
250,000
+200,000
+400% +$4.33M 0.02% 92
2018
Q2 		$1.05M Buy
+50,000
New +$926K 0.01% 95

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Farallon Capital Management's SPPI Position: Q4 2018 in Review

Farallon Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 250,000 shares — an estimated $4.2M sold.

Farallon Capital Management first reported a position in SPPI in Q2 2018 and held it in 2 quarters. The position peaked at $4.2M in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • Farallon Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Farallon Capital Management sold 250,000 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $4.2M.
  • Farallon Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 2 quarters.
  • Farallon Capital Management's Spectrum Pharmaceuticals Inc position peaked at $4.2M in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Farallon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.